newsfilter
← Latest News
GlobeNewswire·

Vallon Pharmaceuticals Announces Issuance of U.S. Patent Covering ADAIR for the Treatment of Cognitive Impairment Associated with COVID-19

- Company in ongoing discussions with a major academic research center for design and execution of proof-of-concept study evaluating ADAIR for the treatment of cognitive impairment associated with COVID-19 PHILADELPHIA, PA, Feb. 28, 2022 (GLOBE N